Search

The article discusses research done in India on the resuse of explanted, resterilized implantable cardioverter-defibrillators. It references a study by Behzad B. Pavri and colleagues, published in a 2012 issue of "Annals of Internal Medicine." The researchers found that such implanted cardiovascular instruments can be reused in a different patient with no increased risk of infection of other complications.

The article offers updates on the Indian Polycap Study about the conception of a polypill for cardiovascular events prevention. Three blood pressure lowering agents, aspirin and statin are said to be the main ingredients of the polypill. The study compared the effects of the polypill and Polycap by Cadila Pharmaceuticals Ltd. in Ahmedabad, India.